FDA
approval
· 2017-08-11
FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved Eletriptan hydrobromide as an original application, authorizing a generic version of eletriptan for the acute treatment of migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)